NCM460D BioVector® Human Normal Colon Mucosal Epithelial Cell Line / NCM460D 人正常结肠黏膜上皮细胞株
- 价 格:¥99860
- 货 号:BioVector® NCM460D
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作微信:1843439339 (QQ同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
BioVector® NCM460D Human Normal Colon Mucosal Epithelial Cell Line / NCM460D 人正常结肠黏膜上皮细胞株
一 产品基本信息与细胞生物学背景
细胞名称:NCM460D(亦常写作 NCM460-D 或衍生自 NCM460 亲本系)。
物种来源:人类(Homo sapiens)。
组织源起与生物学背景(肠道药理学与消化道生理学的黄金“正常”对照):
NCM460D 是一株源自人类正常结肠黏膜上皮组织的体外自发永生化(Spontaneously immortalized)细胞系。该系的原始亲本株(NCM460)最初由科研人员(Moyer 等人)自一名 68 岁的西班牙裔男性(临床上因胃癌接受手术,但结肠切缘病理学证实完全属于组织学正常结肠黏膜)体内分离并原代培养获得。
在消化道体外模型开发中,结肠癌细胞系(如 Caco-2, HT29, HCT116)极为普遍,但这些细胞由于恶性转化,其代谢和信号通路已发生严重变异。为了建立一个能真实表征人类体内正常大肠上皮生理机能的平台,科研人员在不引入任何外源致癌病毒基因(如 SV40 T 突变)或外源转染遗传信息的天然状态下,通过体外长期培养和连续传代,成功筛选出了这株获得无限分裂增殖能力的自发永生化克隆型上皮细胞株 NCM460D。它保留了极高质量的正常结肠上皮细胞功能属性。
核心表型与细胞生物学特征(质控指标):
生长特性与双相培养表型(核心操作细节):
NCM460D 在塑料培养瓶中主要表现为混合型生长特征(Mixed monolayer/suspension culture)。
虽然在常规汇合度下以严格贴壁的单层上皮样生长(Monolayer cells predominate)为主,但当细胞密度上升或处于特定周期时,培养基中会天然出现部分成簇或单散的悬浮/半悬浮细胞(Floating population / "floaters")。核心质控警告:这些悬浮成分绝非死细胞,而是该株系特有的分化或活跃增殖子代亚群。在日常换液与传代时,必须通过离心将贴壁段与悬浮段合并保留,严禁直接抽干弃去悬浮细胞! 表面分子与分泌图谱:经免疫组织化学与分子靶向鉴定,该细胞强表达结肠上皮特异性关联抗原:细胞角蛋白(Cytokeratins)和绒毛蛋白(Villin),同时人类分泌成分(Secretory component)呈强阳性;而针对神经元、内皮细胞或成纤维细胞的特异性抗原检测则表现为绝对阴性。此外,群体中部分特异性亚群能够自发进行黏液(Mucin)的合成与分泌。
致瘤性状态(Tumorigenicity):在其早、中期代数质检中,该细胞表现出正常的生长限制,在软琼脂(Soft agar)中无法克隆化生长,且对无毛裸鼠(Nude mice)或胸腺缺陷小鼠进行皮下接种后不具备致瘤性(Non-tumorigenic)。
然而,由于长期体外传代(In vitro selection压力),晚期代数可能会出现核型异常并获得部分转化特征,实验中需高度关注代数窗口。
生物安全级别:1级(BSL-1)。
二 核心科研价值与肠道屏障/代谢毒理医学应用
N2a/APP695swe 等疾病株需要耐药靶点,而 NCM460D 则作为整条消化道“健康与稳态”的黄金基石:
结肠癌(Colorectal Cancer)研究中的非肿瘤恶性转化“阴性对照”:
在评估新型抗癌靶向化疗药、小分子抑制剂或天然抗肿瘤中药时,NCM460D 常与 Caco-2 或 HT29 等结肠癌靶盘并列应用。通过对比两者的 $IC_{50}$、凋亡诱导率,用以确证化合物是否具备“高效低毒”的肿瘤特异性杀伤窗口,确保其对人体正常肠黏膜不具备显著的细胞毒性。
肠黏膜物理屏障、紧密连接与离子转运(Ion Transport)研究:
在多孔通透性膜(Transwell)上培养时,NCM460D 单层细胞能发育形成具有一定跨上皮电阻(TEER, 通常可达
$120 - 250\ \Omega\cdot\text{cm}^2$)的极化单层。 它天然具备囊性纤维化跨膜电导调节器(CFTR)、钠-钾-2氯共转运体(NKCC1)等离子通道,是研究结肠隐窝(Crypt)中 cAMP、cGMP 和 $Ca^{2+}$ 依赖性氯离子( $Cl^-$)转运、腹泻发生机制的核心模型。 膳食营养素、食品添加剂(如卡拉胶等)以及环境毒素的肠道毒理学评价:
广泛应用于食品卫生和药物代谢(ADME)研究。模拟人类摄入外源物质(抗生素、食品防腐剂、微塑料等)后,正常肠上皮细胞发生细胞信号转导异常、促炎细胞因子(Cytokine production)暴发、氧化应激或胞间紧密连接蛋白(ZO-1, Occludin)断裂的病理演变流线。
三 实验室细胞复苏、双相动态维持、常规传代与质控标准步骤
1. 专用培养基、血清比例与环境物理常数
基础培养基(重点选型):
原厂推荐:INCELL 公司专有的高度富集 M3:10™ 培养基(M310A,已含补充剂、10% 胎牛血清及双抗),该培养基对长期维持 NCM460D 的高拟真上皮表型最为稳定。
通用常规替代:高质量高糖 RPMI-1640 或者是 MEM 基础培养基。
完全培养基典型配方(常规渠道):
高糖 RPMI-1640 或 MEM 基础培养基
加 10% - 15% 优质胎牛血清(FBS)(注:由于该细胞生长较为严苛且带有悬浮亚群,部分实验室推荐首代复苏或状态不佳时将血清浓度上调至 15% 以促进贴壁扩增)。
加 1% 青霉素-链霉素双抗。
物理生长环境:37 摄氏度,恒温、饱和高湿度,含 5% 二氧化碳(
$CO_2$) 的无菌孵箱。
2. 双相混合细胞的复苏与全量留存步序
提前在生物安全柜中准备好干净的 T25 或 T75 培养瓶,注入 5 - 10 mL 预热至 37 ℃ 的完全培养基。
从液氮罐中取出 NCM460D 冻存管,迅速全量浸入 37 ℃ 恒温水浴箱中快速用力晃动,确保在 1 分钟左右令管内冰块完全融化。
用 75% 酒精喷洒消毒外壁,移入安全柜。
将冻存管内的细胞悬液缓慢滴加至盛有 4 - 5 mL 预热完全培养基的 15 mL 离心管中,轻柔颠倒混匀。
以 1000 rpm(约 200 g)进行温和离心 5 分钟。
小心抽干含有 DMSO 的毒性上清液,注意切勿抽到管底。
加入 1.5 mL 新鲜完全培养基,用移液枪轻柔吹打 3 - 5 次重悬细胞沉淀。
将悬液接种至准备好的培养瓶中,十字摇匀,置于 37 ℃ 孵箱中培养。
复苏 24 小时后的核心操作(关键换液工艺):
由于 NCM460D 具有贴壁/悬浮双相特性,复苏 24 小时后,培养基中会有未贴壁的死细胞碎屑,也会混有正常的悬浮活细胞亚群。此时建议采取“半换液或离心换液法”:将培养基吸出至 15 mL 离心管中,1000 rpm 离心 5 分钟,弃上清(去除碎屑);用 5 mL 全新完全培养基重悬管底的悬浮细胞泥,然后再全量倒回原培养瓶中(原瓶壁上已贴有一层单层上皮细胞)。通过该操作,完美保留双相种子。
3. 日常混合传代操作(酶学解离与混合收集法)
传代时机:当贴壁的单层上皮细胞达到 80% - 90% 汇合度 时必须传代。该细胞群体倍增时间相对较慢,约为 32 - 38 小时。通常每 3 - 5 天传代一次。切忌让贴壁层过度长满($\gt 95\%$),否则悬浮段的细胞会过度聚集成极难解离的致密大团块,引发内部接触抑制紊乱和上皮表型老退。
操作流程(混合传代法):
收集悬浮段:首先用移液管直接吸出培养瓶中的全部上清液(内含悬浮的 "floaters" 细胞群),转移至无菌 15 mL 离心管中。
清洗贴壁层:向瓶内残留的贴壁细胞层表面加入无钙镁离子的无菌 PBS 缓冲液轻轻漂洗 1 次,洗净残余血清,随后吸除 PBS。
酶学解离:向瓶内加入适量 0.25% Trypsin-EDTA 消化液(T25 瓶加入 1 mL),使其均匀覆盖细胞层,随后置于 37 ℃ 孵箱中消化。
镜下动态观察:通常消化 1 - 3 分钟。在倒置显微镜下动态观察,一旦发现多角形贴壁细胞回缩变圆、胞间缝隙增大、且轻敲培养瓶时细胞松动向下滑落,立刻向瓶内注入 2 倍体积的含血清完全培养基终止消化。
用移液枪轻柔吹打瓶壁 3 - 4 次使贴壁细胞彻底脱落,调理成均匀的单细胞悬液。
合流离心:将瓶内这部分消化下来的细胞悬液,全部合并倾倒至步骤1中盛有悬浮细胞上清的 15 mL 离心管中(使贴壁段与悬浮段汇合)。
以 1100 rpm 离心 4 - 5 分钟,彻底弃去含有胰酶的上清液。
加入新鲜完全培养基,用移液枪反复轻柔吹打,直至将贴壁和悬浮成分完全打散成单细胞状态。
按照 1:2 至 1:3 的常规保守传代比例(首次传代推荐 1:3 初始铺板密度,确保每 75 $cm^2$ 面积内至少含有 $2 - 8 \times 10^5$ 个活细胞),接种至新培养瓶中,补足完全培养基,放回孵箱。
4. 屏障与毒理实验模型稳定性控制
代数限制与表型漂移(Passage Control):虽然 NCM460D 属于自发永生化细胞系,但长期连续体外传代(通常超过 30 - 40 代以后)会导致其原本的正常非癌变表型发生倾斜,表现为跨上皮电阻值(TEER)无法达标、或逐渐获得软琼脂克隆生长能力。因此,用于屏障评价、毒理测试和离子转运实验的细胞,代数必须严格控制在复苏后的 20 代以内,严禁使用出现严重核型漂移的晚期老化细胞。
状态监测质控:传代时如果由于漏换液导致悬浮大细胞团块无法被胰酶打散,后期会在瓶底形成局部“火山堆样”的异态重叠生长。一旦在镜下频繁观察到极度致密、无法吹散的结节状细胞团,说明群落动力学已变异,建议终止该批次。
5. 细胞长期保存标准
冻存液配方:50% 基础 RPMI-1640/MEM 培养基 + 40% 优质胎牛血清(FBS) + 10% 最高分析级二甲基亚砜(DMSO);或者使用原厂推荐的无血清高保护级细胞冻存液。
梯度冷冻规范:
按照传代法,合并收集处于对数生长最旺盛期(贴壁层汇合度约 80%)、健康度标杆的 NCM460D 贴壁与悬浮细胞,离心吸除上清。
用配制好的冷冻液悬浮并计数,调整细胞终密度至 每毫升 1,500,000 - 3,000,000 个活细胞 之间。
分装入无菌专用冻存管,拧紧管盖,立刻移入标准程序降温盒(Mr. Frosty)。
将降温盒投入 -80 ℃ 超低温冰箱中慢速梯度降温过夜(确保达到
$-1\text{ }^\circ\text{C/min}$ 的标称降温速率)。 24 小时内,迅速将冻存管转移并锁死在液氮罐(-196 ℃)的液相层或气相层中长期存放。严禁在 -80 ℃ 冰箱中无限期搁置,防止微弱的温度震荡破坏该自发永生化细胞特有的双相膜结构完整性。
BioVector® NCM460D Human Normal Colon Mucosal Epithelial Cell Line / NCM460D 人正常结肠黏膜上皮细胞株 (English Version)
I Product General Information and Cell Biological Background
Cell Line Name: NCM460D (Alternative nomenclature: NCM460-D or derived sub-clones of the parent NCM460 line).
Organism Source: Human (Homo sapiens).
Tissue Extract and Background (The Gold-Standard "Normal" Control for Intestinal Pharmacology and GI Physiology):
NCM460D represents a spontaneously immortalized epithelial cell line derived from histologically normal human colon mucosal tissue. The original parental line (NCM460) was isolated by Moyer and colleagues from the transverse colon mucosa of a 68-year-old Hispanic male patient undergoing surgery for gastric carcinoma. Importantly, pathology confirmed the donor's colonic margins were entirely normal, clear of disease, and histologically sound.
While malignant colorectal cancer lines (e.g., Caco-2, HT29, HCT116) are ubiquitous in gastrointestinal research, their severe oncogenic mutations skew metabolic pathways and signaling cascades. To overcome this limitation, NCM460D was established through long-term in vitro cultivation and continuous passaging without the introduction of any heterologous viral oncogenes (such as SV40 Large T antigen) or exogenous transgenes. The resulting line possesses an indefinite replicative lifespan while preserving the non-malignant physiological and functional properties of normal human large intestinal epithelium.
Core Morphological Phenotype and Characterization Parameters:
Biphasic Proliferation Profiling (Critical Operational Detail):
NCM460D exhibits a mixed monolayer/suspension growth phenotype when cultivated on standard tissue culture plasticware. While the culture is dominated by a strictly adherent epithelial-like monolayer at standard densities, it naturally sheds a distinct population of viable single cells or clusters that grow in suspension/semi-suspension ("floaters") as density escalates or cells progress through specific cell cycle checkpoints.
CRITICAL QUALITY CONTROL WARNING: These suspended elements are NOT dead cell fragments; they constitute a highly viable, proliferating sub-population crucial to the line's multi-lineage dynamic state. During routine media replacement and subculturing, this floating segment MUST be harvested, spun down, and combined with the adherent layer. Never aspirate and discard the floating cells.
Surface Antigen and Secretory Footprint: Immunocytochemical and molecular analysis confirms that NCM460D strongly expresses epithelial-specific lineage markers, including cytokeratins and villin, alongside the human secretory component. Conversely, the line tests completely negative for markers specific to neuronal, endothelial, or fibroblastic lineages. Furthermore, specialized sub-populations within the line retain the capacity for spontaneous mucin synthesis and secretion.
Tumorigenic Assessment: At early and mid-passage stages, NCM460D exhibits strict growth constraints. It fails to form colonies in soft agar assays and is non-tumorigenic when subcutaneously inoculated into athymic nude mice or thymus-deficient animal matrices. However, because extended in vitro passaging introduces long-term selection pressure, late-passage cultures may undergo karyotypic drifting and pick up transformed traits. Strict tracking of passage numbers is mandatory.
Biosafety Threshold: Rated at Biosafety Level 1 (BSL-1).
II Strategic Research Value and Intestinal Barrier/Toxicological Applications
While disease-specific cell lines are implemented to isolate resistance markers, NCM460D functions as a crucial "healthy baseline" control for gastrointestinal physiology:
The Non-Malignant "Negative Control" in Colorectal Cancer (CRC) Screenings:
When evaluating novel targeted chemotherapeutics, small-molecule inhibitors, or natural anti-tumor botanical compounds, investigators deploy NCM460D in parallel with colorectal cancer lines (e.g., Caco-2, HT29). By comparing comparative $IC_{50}$ values and apoptosis induction rates, researchers establish whether a compound exhibits a true, tumor-specific therapeutic window without causing toxic off-target damage to normal, healthy intestinal mucosa.
Intestinal Mucosal Physical Barrier, Tight Junctions, and Ion Transport:
When cultured on porous permeable supports (Transwell inserts), NCM460D monolayers develop polarized configurations that generate a measurable transepithelial electrical resistance (TEER, standardly scaling to $120 - 250\ \Omega\cdot\text{cm}^2$). It constitutively expresses vital ion channels, including the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Sodium-Potassium-Chloride Cotransporter (NKCC1), rendering it an optimal model for investigating cAMP-, cGMP-, and $Ca^{2+}$-dependent chloride ($Cl^-$) transport dynamics across colonic crypt architectures during diarrheal pathogen exposure.
Intestinal Toxicological Evaluation of Nutrients, Food Additives, and Xenobiotics:
NCM460D is widely integrated into food safety testing and ADME (Absorption, Distribution, Metabolism, and Excretion) studies. It simulates the human gut's physiological response to ingested substances—such as therapeutic antibiotics, food emulsifiers (e.g., carrageenan), microplastics, or environmental toxins—mapping intracellular signaling disruptions, pro-inflammatory cytokine cascades, oxidative stress profiling, and the degradation of intercellular tight junction proteins (ZO-1, Occludin).
III Laboratory Thawing, Biphasic Cultivation, Passaging, and Quality Controls
1. Basal Media Optimization and Physical Environmental Settings
Basal Medium Base (Strict Selection Requirements):
Primary Manufacturer Recommendation: INCELL's proprietary, enriched M3:10™ medium (M310A, pre-formulated with essential supplements, 10% Fetal Bovine Serum, and antibiotics). This matrix yields the highest long-term stability for preserving authentic human colonic epithelial phenotypes.
Standard Laboratory Alternative: Premium High-Glucose RPMI-1640 or standard MEM basal formulation.
Complete Growth Matrix Formulation (Standard Alternate Configuration):
High-Glucose RPMI-1640 or MEM basal template
Supplemented with 10% – 15% premium Fetal Bovine Serum (FBS). Note: Because this line can be fastidious and relies on a sensitive balance between adherent and floating segments, elevating the serum concentration to 15% during initial post-thaw recovery or phases of low viability is highly recommended to stimulate attachment and growth.
Fortified with 1% standard Penicillin-Streptomycin dual antibiotic cocktail.
Physical Processing Constants: Calibrate the incubator strictly to 37 °C, packed with 5% Carbon Dioxide ($CO_2$) under continuous humified saturation conditions.
2. Biphasic Culture Thawing and Complete Cell Recovery Protocol
Pre-warm a sterile T25 or T75 culture flask filled with 5 – 10 mL of complete growth medium to 37 °C inside the biosafety workstation.
Retrieve the NCM460D cryovial from liquid nitrogen storage and submerge it instantly within a 37 °C water bath. Agitate continuously to melt the internal matrix within 60–90 seconds.
Mist the exterior shell with 75% ethanol before transfer into the sterile workstation.
Draw up the liquid and transfer it slowly into a 15 mL conical tube containing 4 – 5 mL of pre-warmed complete growth medium to dilute the toxic DMSO footprint.
Centrifuge the suspension at a gentle velocity of 1000 rpm (~200 g) for 5 minutes.
Aspirate the chemical-laden supernatant completely, taking care not to disturb the underlying pellet.
Administer 1.5 mL of fresh complete growth medium onto the pellet, resuspending via gentle pipetting (3 – 5 strokes max).
Dispense the cells into the prepared culture flask, mix gently in a cross pattern, and place into the 37 °C incubator.
Critical Handling Step at 24 Hours Post-Thaw (Biphasic Retention Wash):
Because NCM460D exhibits a dual adherent/suspension nature, the culture fluid at 24 hours will contain a mixture of dead cell fragments from cryo-stress and healthy, viable floating epithelial subsets. To protect this delicate population, implement a "centrifugal media replacement method": Aspirate the entire culture supernatant into a sterile 15 mL tube and centrifuge it at 1000 rpm for 5 minutes. Discard the supernatant (removing debris), resuspend the remaining viable floating cell pellet in 5 mL of fresh complete growth medium, and return this suspension back into the original flask (where the initial adherent monolayer is already fixed to the plastic surface). This process fully re-establishes the crucial biphasic seed stock.
3. Routine Biphasic Subculturing and Passaging Routines
Confluency Assessment Control: Initialize passaging workflows when the adherent epithelial monolayer achieves 80% – 90% confluency. The population doubling time of NCM460D ranges from 32 to 38 hours under optimal conditions; expect a standard passaging schedule every 3 to 5 days. Never allow the adherent monolayer to become over-confluent ($\gt 95\%$), as the floating segment will form dense, highly compacted aggregates that resist enzymatic dissociation. This induces contact-inhibition stress and triggers phenotypic degradation.
Passaging Execution Steps (Unified Mixed-Phase Method):
Harvest the Floating Segment: Directly aspirate the entire volume of spent growth fluid (containing the vital floating sub-population) and transfer it into a sterile 15 mL conical tube.
Wash the Adherent Bed: Rinse the remaining adherent monolayer gently with sterile, calcium/magnesium-free PBS to remove residual serum proteins, then aspirate and discard the PBS wash.
Enzymatic Dissociation: Apply an appropriate layer of 0.25% Trypsin-EDTA solution (typically 1 mL for a T25 format) directly onto the monolayer and incubate at 37 °C.
Microscopic Tracking: Maintain continuous visual monitoring under the microscope. Trypsinization typically completes within 1 – 3 minutes at 37 °C. The moment the polygonal adherent cells contract, cell boundaries expand, and cells slide off the surface upon gentle tapping, immediately add 2 volumes of serum-fortified complete growth medium to halt enzymatic cleavage.
Gently pipette the suspension 3 to 4 times against the flask wall to ensure complete detachment and break up early clusters.
Phase Convergence: Transfer this trypsinized cell suspension directly into the same 15 mL tube containing the original floating cell supernatant harvested in Step 1 (merging both adherent and suspension fractions).
Centrifuge the unified suspension at 1100 rpm for 4 – 5 minutes, then completely aspirate and discard the trypsin-laden fluid.
Resuspend the consolidated pellet in fresh complete growth medium, pipetting gently but thoroughly until both fractions are dissociated into a homogenous single-cell suspension.
Distribute the cells into new flasks utilizing standard conservative split ratios of 1:2 to 1:3 (ensuring a minimum seeding density of $2 - 8 \times 10^5$ viable cells per 75 $cm^2$ surface area). Top off with complete growth medium and return to the incubator.
4. Barrier and Toxicological Assay Quality Controls
Passage Threshold Restrictions and Phenotypic Drift: Although NCM460D is a spontaneously immortalized line, extended, continuous cultivation (typically beyond 30 to 40 passages post-receipt) can shift its non-malignant phenotype. This drift presents as a progressive loss of tight junction formation (indicated by a drop in baseline TEER values) or the spontaneous acquisition of anchorage-independent growth in soft agar. Consequently, cells designated for barrier integrity evaluation, toxicological mapping, or ion transport assays must be strictly restricted to fewer than 20 passages post-thaw. Never use late-passage cultures that exhibit karyotypic drift.
Morphological Aberration Audit: If regular media replacements are missed, the floating aggregates can form dense, nodular clusters that resist trypsinization. This causes irregular, multi-layered "volcanic-like" stacking on the flask floor. If these tightly bound, indissociable cell nodules appear frequently under the microscope, the culture dynamics have drifted, and the batch must be discarded.
5. Long-Term Cryopreservation Parameters
Cryoprotectant Preservation Formula: 50% basal RPMI-1640/MEM growth medium blended with 40% premium Fetal Bovine Serum (FBS) and 10% analytical-grade Dimethyl Sulfoxide (DMSO), or a certified serum-free, high-protection commercial freezing matrix.
Controlled Gradient Freezing Protocol:
Harvest highly viable, mid-log phase cultures (adherent monolayer at approximately 80% confluency), pooling both the adherent and floating segments according to the unified passaging protocol. Centrifuge and isolate the pellet.
Resuspend the cells in the pre-chilled cryoprotectant matrix, adjusting the target density to between 1,500,000 and 3,000,000 viable cells per milliliter.
Transfer the solution into sterile cryovials, tightening the caps securely to maintain an airtight seal.
Place the vials immediately into a standard controlled-rate cooling container (e.g., Mr. Frosty).
Deposit the cooling container inside a -80 °C ultra-low freezer overnight to execute a steady cooling rate of -1 °C/minute.
Within 24 hours, quickly transfer the vials into liquid nitrogen storage tanks (-196 °C) for long-term preservation. Do not store vials indefinitely inside a -80 °C freezer, as minor temperature variations can compromise membrane integrity and degrade the specialized biphasic structure of this spontaneously immortalized epithelial line.
BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
电话:400-800-2947
工作QQ/微信同号:1843439339
网址http://www.biovector.net
- 公告/新闻




